| Symbol |
Name |
|
A2M
|
alpha-2-macroglobulin
|
|
AADAC
|
arylacetamide deacetylase
|
|
AATF
|
apoptosis antagonizing transcription factor
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCA5
|
ATP-binding cassette, sub-family A (ABC1), member 5
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC10
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 10
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3
|
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ABCC6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6
|
|
ABCD2
|
ATP-binding cassette, sub-family D (ALD), member 2
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABI1
|
abl-interactor 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACACA
|
acetyl-CoA carboxylase alpha
|
|
ACAT1
|
acetyl-CoA acetyltransferase 1
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
|
ACRBP
|
acrosin binding protein
|
|
ACTC1
|
actin, alpha, cardiac muscle 1
|
|
ACTL6A
|
actin-like 6A
|
|
ACTR2
|
ARP2 actin-related protein 2 homolog (yeast)
|
|
ACTR3
|
ARP3 actin-related protein 3 homolog (yeast)
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM8
|
ADAM metallopeptidase domain 8
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
|
ADAMTS9
|
ADAM metallopeptidase with thrombospondin type 1 motif, 9
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADORA1
|
adenosine A1 receptor
|
|
ADORA2B
|
adenosine A2b receptor
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AEN
|
apoptosis enhancing nuclease
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGR2
|
anterior gradient 2
|
|
AGR3
|
anterior gradient 3
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AHRR
|
aryl-hydrocarbon receptor repressor
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AIM2
|
absent in melanoma 2
|
|
AIRE
|
autoimmune regulator
|
|
AKAP8
|
A kinase (PRKA) anchor protein 8
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
AKR1C1
|
aldo-keto reductase family 1, member C1
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALDOA
|
aldolase A, fructose-bisphosphate
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALOX5AP
|
arachidonate 5-lipoxygenase-activating protein
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
ALPPL2
|
alkaline phosphatase, placental-like 2
|
|
AMBRA1
|
autophagy/beclin-1 regulator 1
|
|
AMH
|
anti-Mullerian hormone
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
ANGPTL7
|
angiopoietin-like 7
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
ANP32B
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
ANXA1
|
annexin A1
|
|
ANXA5
|
annexin A5
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APBB1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65)
|
|
APCS
|
amyloid P component, serum
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA4
|
apolipoprotein A-IV
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3A
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A
|
|
APOBEC3B
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B
|
|
APOBEC3F
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOE
|
apolipoprotein E
|
|
APOL1
|
apolipoprotein L, 1
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
APPL2
|
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP4
|
aquaporin 4
|
|
AQP5
|
aquaporin 5
|
|
AR
|
androgen receptor
|
|
ARAF
|
A-Raf proto-oncogene, serine/threonine kinase
|
|
AREG
|
amphiregulin
|
|
ARG1
|
arginase 1
|
|
ARG2
|
arginase 2
|
|
ARHGEF2
|
Rho/Rac guanine nucleotide exchange factor (GEF) 2
|
|
ARHGEF6
|
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
ARSA
|
arylsulfatase A
|
|
ASAH1
|
N-acylsphingosine amidohydrolase (acid ceramidase) 1
|
|
ASAH2
|
N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2
|
|
ASCC1
|
activating signal cointegrator 1 complex subunit 1
|
|
ASH1L
|
ash1 (absent, small, or homeotic)-like (Drosophila)
|
|
ASIC3
|
acid sensing (proton gated) ion channel 3
|
|
ATAD5
|
ATPase family, AAA domain containing 5
|
|
ATF1
|
activating transcription factor 1
|
|
ATF2
|
activating transcription factor 2
|
|
ATF3
|
activating transcription factor 3
|
|
ATF4
|
activating transcription factor 4
|
|
ATF6
|
activating transcription factor 6
|
|
ATG101
|
autophagy related 101
|
|
ATG13
|
autophagy related 13
|
|
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae)
|
|
ATG5
|
autophagy related 5
|
|
ATG7
|
autophagy related 7
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP5B
|
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide
|
|
ATP6AP2
|
ATPase, H+ transporting, lysosomal accessory protein 2
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
|
AURKA
|
aurora kinase A
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
B3GALT4
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4
|
|
B4GALNT2
|
beta-1,4-N-acetyl-galactosaminyl transferase 2
|
|
BACH1
|
BTB and CNC homology 1, basic leucine zipper transcription factor 1
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BAG6
|
BCL2-associated athanogene 6
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAMBI
|
BMP and activin membrane-bound inhibitor
|
|
BATF2
|
basic leucine zipper transcription factor, ATF-like 2
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCAP31
|
B-cell receptor-associated protein 31
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCOR
|
BCL6 corepressor
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BGN
|
biglycan
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
|
BIN1
|
bridging integrator 1
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BLVRA
|
biliverdin reductase A
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRD2
|
bromodomain containing 2
|
|
BRD4
|
bromodomain containing 4
|
|
BRD7
|
bromodomain containing 7
|
|
BSG
|
basigin (Ok blood group)
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTC
|
betacellulin
|
|
BTG2
|
BTG family, member 2
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
C1QBP
|
complement component 1, q subcomponent binding protein
|
|
C2ORF40
|
chromosome 2 open reading frame 40
|
|
C3
|
complement component 3
|
|
C5
|
complement component 5
|
|
C5AR1
|
complement component 5a receptor 1
|
|
C6
|
complement component 6
|
|
C7
|
complement component 7
|
|
C8B
|
complement component 8, beta polypeptide
|
|
C9
|
complement component 9
|
|
CAB39
|
calcium binding protein 39
|
|
CALB2
|
calbindin 2
|
|
CALCR
|
calcitonin receptor
|
|
CALR
|
calreticulin
|
|
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta
|
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CAPN2
|
calpain 2, (m/II) large subunit
|
|
CAPN3
|
calpain 3, (p94)
|
|
CAPNS1
|
calpain, small subunit 1
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CARM1
|
coactivator-associated arginine methyltransferase 1
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP4
|
caspase 4, apoptosis-related cysteine peptidase
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL24
|
chemokine (C-C motif) ligand 24
|
|
CCL28
|
chemokine (C-C motif) ligand 28
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCL8
|
chemokine (C-C motif) ligand 8
|
|
CCNA1
|
cyclin A1
|
|
CCNA2
|
cyclin A2
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CCNE2
|
cyclin E2
|
|
CCNG2
|
cyclin G2
|
|
CCNT1
|
cyclin T1
|
|
CCR10
|
chemokine (C-C motif) receptor 10
|
|
CCR4
|
chemokine (C-C motif) receptor 4
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CCR8
|
chemokine (C-C motif) receptor 8
|
|
CCR9
|
chemokine (C-C motif) receptor 9
|
|
CCRN4L
|
CCR4 carbon catabolite repression 4-like (S. cerevisiae)
|
|
CD14
|
CD14 molecule
|
|
CD163
|
CD163 molecule
|
|
CD1A
|
CD1a molecule
|
|
CD1D
|
CD1d molecule
|
|
CD209
|
CD209 molecule
|
|
CD24
|
CD24 molecule
|
|
CD274
|
CD274 molecule
|
|
CD276
|
CD276 molecule
|
|
CD28
|
CD28 molecule
|
|
CD33
|
CD33 molecule
|
|
CD34
|
CD34 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD38
|
CD38 molecule
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD47
|
CD47 molecule
|
|
CD52
|
CD52 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD63
|
CD63 molecule
|
|
CD69
|
CD69 molecule
|
|
CD80
|
CD80 molecule
|
|
CD81
|
CD81 molecule
|
|
CD82
|
CD82 molecule
|
|
CD83
|
CD83 molecule
|
|
CD86
|
CD86 molecule
|
|
CDC25A
|
cell division cycle 25A
|
|
CDC25B
|
cell division cycle 25B
|
|
CDC25C
|
cell division cycle 25C
|
|
CDC42
|
cell division cycle 42
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDK8
|
cyclin-dependent kinase 8
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2AIP
|
CDKN2A interacting protein
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)
|
|
CDKN3
|
cyclin-dependent kinase inhibitor 3
|
|
CDT1
|
chromatin licensing and DNA replication factor 1
|
|
CDX1
|
caudal type homeobox 1
|
|
CDX2
|
caudal type homeobox 2
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta
|
|
CEBPE
|
CCAAT/enhancer binding protein (C/EBP), epsilon
|
|
CEBPG
|
CCAAT/enhancer binding protein (C/EBP), gamma
|
|
CERK
|
ceramide kinase
|
|
CERS2
|
ceramide synthase 2
|
|
CERS4
|
ceramide synthase 4
|
|
CERS6
|
ceramide synthase 6
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFB
|
complement factor B
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CGB7
|
chorionic gonadotropin, beta polypeptide 7
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CIDEB
|
cell death-inducing DFFA-like effector b
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CKS1B
|
CDC28 protein kinase regulatory subunit 1B
|
|
CKS1BP7
|
CDC28 protein kinase regulatory subunit 1B pseudogene 7
|
|
CLDN1
|
claudin 1
|
|
CLDN11
|
claudin 11
|
|
CLDN7
|
claudin 7
|
|
CLEC4M
|
C-type lectin domain family 4, member M
|
|
CLEC6A
|
C-type lectin domain family 6, member A
|
|
CLEC7A
|
C-type lectin domain family 7, member A
|
|
CLSPN
|
claspin
|
|
CLU
|
clusterin
|
|
CMIP
|
c-Maf inducing protein
|
|
CNBP
|
CCHC-type zinc finger, nucleic acid binding protein
|
|
COL10A1
|
collagen, type X, alpha 1
|
|
COL12A1
|
collagen, type XII, alpha 1
|
|
COL16A1
|
collagen, type XVI, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COMP
|
cartilage oligomeric matrix protein
|
|
CPD
|
carboxypeptidase D
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CREM
|
cAMP responsive element modulator
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR2
|
corticotropin releasing hormone receptor 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAB
|
crystallin, alpha B
|
|
CSE1L
|
CSE1 chromosome segregation 1-like (yeast)
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CSK
|
c-src tyrosine kinase
|
|
CSN2
|
casein beta
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CSNK2B
|
casein kinase 2, beta polypeptide
|
|
CSRP3
|
cysteine and glycine-rich protein 3 (cardiac LIM protein)
|
|
CSTF2
|
cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CTBP1
|
C-terminal binding protein 1
|
|
CTDP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1
|
|
CTGF
|
connective tissue growth factor
|
|
CTHRC1
|
collagen triple helix repeat containing 1
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CTSB
|
cathepsin B
|
|
CTSD
|
cathepsin D
|
|
CTSE
|
cathepsin E
|
|
CTSK
|
cathepsin K
|
|
CTSL
|
cathepsin L
|
|
CUL3
|
cullin 3
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CXCL3
|
chemokine (C-X-C motif) ligand 3
|
|
CXCL6
|
chemokine (C-X-C motif) ligand 6
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR6
|
chemokine (C-X-C motif) receptor 6
|
|
CXXC1
|
CXXC finger protein 1
|
|
CYB5A
|
cytochrome b5 type A (microsomal)
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYCS
|
cytochrome c, somatic
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP26A1
|
cytochrome P450, family 26, subfamily A, polypeptide 1
|
|
CYP27A1
|
cytochrome P450, family 27, subfamily A, polypeptide 1
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP4A11
|
cytochrome P450, family 4, subfamily A, polypeptide 11
|
|
CYP4F2
|
cytochrome P450, family 4, subfamily F, polypeptide 2
|
|
CYP7A1
|
cytochrome P450, family 7, subfamily A, polypeptide 1
|
|
CYP8B1
|
cytochrome P450, family 8, subfamily B, polypeptide 1
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DACH1
|
dachshund family transcription factor 1
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DAP3
|
death associated protein 3
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAXX
|
death-domain associated protein
|
|
DCK
|
deoxycytidine kinase
|
|
DCN
|
decorin
|
|
DCT
|
dopachrome tautomerase
|
|
DDB1
|
damage-specific DNA binding protein 1, 127kDa
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDIT4
|
DNA-damage-inducible transcript 4
|
|
DDR2
|
discoidin domain receptor tyrosine kinase 2
|
|
DDT
|
D-dopachrome tautomerase
|
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEFB1
|
defensin, beta 1
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEFB104A
|
defensin, beta 104A
|
|
DEFB104B
|
defensin, beta 104B
|
|
DEFB4A
|
defensin, beta 4A
|
|
DFFA
|
DNA fragmentation factor, 45kDa, alpha polypeptide
|
|
DFFB
|
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase)
|
|
DFNA5
|
deafness, autosomal dominant 5
|
|
DGKB
|
diacylglycerol kinase, beta 90kDa
|
|
DGKQ
|
diacylglycerol kinase, theta 110kDa
|
|
DGKZ
|
diacylglycerol kinase, zeta
|
|
DHRS9
|
dehydrogenase/reductase (SDR family) member 9
|
|
DHX58
|
DEXH (Asp-Glu-X-His) box polypeptide 58
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLK1
|
delta-like 1 homolog (Drosophila)
|
|
DLL1
|
delta-like 1 (Drosophila)
|
|
DLL4
|
delta-like 4 (Drosophila)
|
|
DMD
|
dystrophin
|
|
DMP1
|
dentin matrix acidic phosphoprotein 1
|
|
DNAJA3
|
DnaJ (Hsp40) homolog, subfamily A, member 3
|
|
DNASE1
|
deoxyribonuclease I
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DOCK2
|
dedicator of cytokinesis 2
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPP7
|
dipeptidyl-peptidase 7
|
|
DRAM2
|
DNA-damage regulated autophagy modulator 2
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
DSC2
|
desmocollin 2
|
|
DSCAM
|
Down syndrome cell adhesion molecule
|
|
DTNA
|
dystrobrevin, alpha
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DUSP2
|
dual specificity phosphatase 2
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
DYRK1A
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F3
|
E2F transcription factor 3
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EEF1A1
|
eukaryotic translation elongation factor 1 alpha 1
|
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2
|
|
EEF2K
|
eukaryotic elongation factor 2 kinase
|
|
EFNA1
|
ephrin-A1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EGR1
|
early growth response 1
|
|
EHF
|
ets homologous factor
|
|
EIF2A
|
eukaryotic translation initiation factor 2A, 65kDa
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EIF2AK4
|
eukaryotic translation initiation factor 2 alpha kinase 4
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF3I
|
eukaryotic translation initiation factor 3, subunit I
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EIF5A
|
eukaryotic translation initiation factor 5A
|
|
EIF6
|
eukaryotic translation initiation factor 6
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific )
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ELL
|
elongation factor RNA polymerase II
|
|
ELN
|
elastin
|
|
ENC1
|
ectodermal-neural cortex 1 (with BTB domain)
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
|
ENTPD4
|
ectonucleoside triphosphate diphosphohydrolase 4
|
|
EP300
|
E1A binding protein p300
|
|
EP400
|
E1A binding protein p400
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHA1
|
EPH receptor A1
|
|
EPHA2
|
EPH receptor A2
|
|
EPHB2
|
EPH receptor B2
|
|
EPHB4
|
EPH receptor B4
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
EPX
|
eosinophil peroxidase
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
EREG
|
epiregulin
|
|
ERF
|
Ets2 repressor factor
|
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1
|
|
ERO1L
|
ERO1-like (S. cerevisiae)
|
|
ERRFI1
|
ERBB receptor feedback inhibitor 1
|
|
ESM1
|
endothelial cell-specific molecule 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ESRRG
|
estrogen-related receptor gamma
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
ETV1
|
ets variant 1
|
|
ETV6
|
ets variant 6
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
EZR
|
ezrin
|
|
F11R
|
F11 receptor
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAM129B
|
family with sequence similarity 129, member B
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FASN
|
fatty acid synthase
|
|
FBLN1
|
fibulin 1
|
|
FBLN5
|
fibulin 5
|
|
FBXO18
|
F-box protein, helicase, 18
|
|
FBXO32
|
F-box protein 32
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCMR
|
Fc fragment of IgM receptor
|
|
FCRL3
|
Fc receptor-like 3
|
|
FDPS
|
farnesyl diphosphate synthase
|
|
FERMT1
|
fermitin family member 1
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGF19
|
fibroblast growth factor 19
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF21
|
fibroblast growth factor 21
|
|
FGF4
|
fibroblast growth factor 4
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGL1
|
fibrinogen-like 1
|
|
FGL2
|
fibrinogen-like 2
|
|
FHIT
|
fragile histidine triad
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FIS1
|
fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae)
|
|
FKBP4
|
FK506 binding protein 4, 59kDa
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLG
|
filaggrin
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FLVCR1
|
feline leukemia virus subgroup C cellular receptor 1
|
|
FN1
|
fibronectin 1
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXA1
|
forkhead box A1
|
|
FOXD1
|
forkhead box D1
|
|
FOXL2
|
forkhead box L2
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FOXP3
|
forkhead box P3
|
|
FOXP4
|
forkhead box P4
|
|
FPR1
|
formyl peptide receptor 1
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FTH1
|
ferritin, heavy polypeptide 1
|
|
FTMT
|
ferritin mitochondrial
|
|
FUBP1
|
far upstream element (FUSE) binding protein 1
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
|
FUS
|
FUS RNA binding protein
|
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
FUT5
|
fucosyltransferase 5 (alpha (1,3) fucosyltransferase)
|
|
FUT6
|
fucosyltransferase 6 (alpha (1,3) fucosyltransferase)
|
|
FUT7
|
fucosyltransferase 7 (alpha (1,3) fucosyltransferase)
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
FZD4
|
frizzled class receptor 4
|
|
GABPA
|
GA binding protein transcription factor, alpha subunit 60kDa
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GADD45B
|
growth arrest and DNA-damage-inducible, beta
|
|
GADD45G
|
growth arrest and DNA-damage-inducible, gamma
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GAPDHS
|
glyceraldehyde-3-phosphate dehydrogenase, spermatogenic
|
|
GAS6
|
growth arrest-specific 6
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GATA3
|
GATA binding protein 3
|
|
GATA6
|
GATA binding protein 6
|
|
GBP1
|
guanylate binding protein 1, interferon-inducible
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GCLM
|
glutamate-cysteine ligase, modifier subunit
|
|
GCNT2
|
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group)
|
|
GCSAM
|
germinal center-associated, signaling and motility
|
|
GDF15
|
growth differentiation factor 15
|
|
GFI1
|
growth factor independent 1 transcription repressor
|
|
GGCT
|
gamma-glutamylcyclotransferase
|
|
GGT2
|
gamma-glutamyltransferase 2
|
|
GH1
|
growth hormone 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GIT2
|
G protein-coupled receptor kinase interacting ArfGAP 2
|
|
GJA4
|
gap junction protein, alpha 4, 37kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLI3
|
GLI family zinc finger 3
|
|
GLIPR1
|
GLI pathogenesis-related 1
|
|
GLS2
|
glutaminase 2 (liver, mitochondrial)
|
|
GLTSCR2
|
glioma tumor suppressor candidate region gene 2
|
|
GLUL
|
glutamate-ammonia ligase
|
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13
|
|
GNA14
|
guanine nucleotide binding protein (G protein), alpha 14
|
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
|
|
GNAS
|
GNAS complex locus
|
|
GNLY
|
granulysin
|
|
GOLGA2
|
golgin A2
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GPI
|
glucose-6-phosphate isomerase
|
|
GPR68
|
G protein-coupled receptor 68
|
|
GPR83
|
G protein-coupled receptor 83
|
|
GPRC5A
|
G protein-coupled receptor, class C, group 5, member A
|
|
GPX1
|
glutathione peroxidase 1
|
|
GPX2
|
glutathione peroxidase 2
|
|
GPX4
|
glutathione peroxidase 4
|
|
GPX8
|
glutathione peroxidase 8 (putative)
|
|
GRAMD4
|
GRAM domain containing 4
|
|
GREB1
|
growth regulation by estrogen in breast cancer 1
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
GRHL3
|
grainyhead-like 3 (Drosophila)
|
|
GRID2
|
glutamate receptor, ionotropic, delta 2
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRP
|
gastrin-releasing peptide
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTO2
|
glutathione S-transferase omega 2
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GTF2I
|
general transcription factor IIi
|
|
GTF3C2
|
general transcription factor IIIC, polypeptide 2, beta 110kDa
|
|
GUCY2C
|
guanylate cyclase 2C
|
|
GZF1
|
GDNF-inducible zinc finger protein 1
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H2AFX
|
H2A histone family, member X
|
|
H2AFZ
|
H2A histone family, member Z
|
|
H6PD
|
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAS1
|
hyaluronan synthase 1
|
|
HAS2
|
hyaluronan synthase 2
|
|
HBB
|
hemoglobin, beta
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HBG1
|
hemoglobin, gamma A
|
|
HCAR1
|
hydroxycarboxylic acid receptor 1
|
|
HCRTR1
|
hypocretin (orexin) receptor 1
|
|
HCST
|
hematopoietic cell signal transducer
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HDAC4
|
histone deacetylase 4
|
|
HDAC7
|
histone deacetylase 7
|
|
HDC
|
histidine decarboxylase
|
|
HDGF
|
hepatoma-derived growth factor
|
|
HECW1
|
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1
|
|
HEMGN
|
hemogen
|
|
HERPUD1
|
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HEXIM1
|
hexamethylene bis-acetamide inducible 1
|
|
HFE2
|
hemochromatosis type 2 (juvenile)
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HGFAC
|
HGF activator
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIF3A
|
hypoxia inducible factor 3, alpha subunit
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HIST2H2BE
|
histone cluster 2, H2be
|
|
HIST3H3
|
histone cluster 3, H3
|
|
HK2
|
hexokinase 2
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-F
|
major histocompatibility complex, class I, F
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGB1
|
high mobility group box 1
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HNRNPL
|
heterogeneous nuclear ribonucleoprotein L
|
|
HNRNPU
|
heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A)
|
|
HOPX
|
HOP homeobox
|
|
HOXA10
|
homeobox A10
|
|
HOXA7
|
homeobox A7
|
|
HOXA9
|
homeobox A9
|
|
HOXB3
|
homeobox B3
|
|
HOXB4
|
homeobox B4
|
|
HOXC4
|
homeobox C4
|
|
HOXC8
|
homeobox C8
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HPN
|
hepsin
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRH1
|
histamine receptor H1
|
|
HRH4
|
histamine receptor H4
|
|
HRK
|
harakiri, BCL2 interacting protein
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
HSPA14
|
heat shock 70kDa protein 14
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPB8
|
heat shock 22kDa protein 8
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
|
HSPH1
|
heat shock 105kDa/110kDa protein 1
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
HTT
|
huntingtin
|
|
IAPP
|
islet amyloid polypeptide
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICAM3
|
intercellular adhesion molecule 3
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IER3IP1
|
immediate early response 3 interacting protein 1
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IFI27
|
interferon, alpha-inducible protein 27
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFIT1
|
interferon-induced protein with tetratricopeptide repeats 1
|
|
IFIT2
|
interferon-induced protein with tetratricopeptide repeats 2
|
|
IFIT3
|
interferon-induced protein with tetratricopeptide repeats 3
|
|
IFN1@
|
interferon, type 1, cluster
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IFNL1
|
interferon, lambda 1
|
|
IFNL2
|
interferon, lambda 2
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IGH
|
immunoglobulin heavy locus
|
|
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker)
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL10
|
interleukin 10
|
|
IL11
|
interleukin 11
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL13
|
interleukin 13
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL17F
|
interleukin 17F
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL22
|
interleukin 22
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL24
|
interleukin 24
|
|
IL25
|
interleukin 25
|
|
IL27
|
interleukin 27
|
|
IL27RA
|
interleukin 27 receptor, alpha
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL2RB
|
interleukin 2 receptor, beta
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL31
|
interleukin 31
|
|
IL32
|
interleukin 32
|
|
IL33R
|
interleukin 33 receptor
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IL7
|
interleukin 7
|
|
IL7R
|
interleukin 7 receptor
|
|
IL9
|
interleukin 9
|
|
ILK
|
integrin-linked kinase
|
|
INHBA
|
inhibin, beta A
|
|
INHBB
|
inhibin, beta B
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
IRAK3
|
interleukin-1 receptor-associated kinase 3
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRF8
|
interferon regulatory factor 8
|
|
IRF9
|
interferon regulatory factor 9
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGAE
|
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB1BP1
|
integrin beta 1 binding protein 1
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
ITPR2
|
inositol 1,4,5-trisphosphate receptor, type 2
|
|
JAG1
|
jagged 1
|
|
JAG2
|
jagged 2
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JCHAIN
|
joining chain of multimeric IgA and IgM
|
|
JUN
|
jun proto-oncogene
|
|
JUNB
|
jun B proto-oncogene
|
|
JUND
|
jun D proto-oncogene
|
|
KAT2A
|
K(lysine) acetyltransferase 2A
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KAT8
|
K(lysine) acetyltransferase 8
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNN3
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KCTD15
|
potassium channel tetramerization domain containing 15
|
|
KDM3A
|
lysine (K)-specific demethylase 3A
|
|
KDM4A
|
lysine (K)-specific demethylase 4A
|
|
KDM4B
|
lysine (K)-specific demethylase 4B
|
|
KDM4C
|
lysine (K)-specific demethylase 4C
|
|
KDR
|
kinase insert domain receptor
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KIDINS220
|
kinase D-interacting substrate, 220kDa
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KLB
|
klotho beta
|
|
KLF1
|
Kruppel-like factor 1 (erythroid)
|
|
KLF10
|
Kruppel-like factor 10
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLF9
|
Kruppel-like factor 9
|
|
KLK1
|
kallikrein 1
|
|
KLK10
|
kallikrein-related peptidase 10
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLRF1
|
killer cell lectin-like receptor subfamily F, member 1
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
|
KNG1
|
kininogen 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT31
|
keratin 31, type I
|
|
KRT4
|
keratin 4, type II
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LAMA5
|
laminin, alpha 5
|
|
LAMC2
|
laminin, gamma 2
|
|
LATS2
|
large tumor suppressor kinase 2
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCN2
|
lipocalin 2
|
|
LDHA
|
lactate dehydrogenase A
|
|
LDHB
|
lactate dehydrogenase B
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEP
|
leptin
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LIF
|
leukemia inhibitory factor
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LMNA
|
lamin A/C
|
|
LMX1B
|
LIM homeobox transcription factor 1, beta
|
|
LOX
|
lysyl oxidase
|
|
LOXL2
|
lysyl oxidase-like 2
|
|
LPAR1
|
lysophosphatidic acid receptor 1
|
|
LPAR3
|
lysophosphatidic acid receptor 3
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTA
|
lymphotoxin alpha
|
|
LTB4R
|
leukotriene B4 receptor
|
|
LTB4R2
|
leukotriene B4 receptor 2
|
|
LTF
|
lactotransferrin
|
|
LY6D
|
lymphocyte antigen 6 complex, locus D
|
|
LY75
|
lymphocyte antigen 75
|
|
LY96
|
lymphocyte antigen 96
|
|
MACROD1
|
MACRO domain containing 1
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B
|
|
MAFF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F
|
|
MAGEA11
|
melanoma antigen family A11
|
|
MAGEH1
|
melanoma antigen family H1
|
|
MAGI1
|
membrane associated guanylate kinase, WW and PDZ domain containing 1
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP2K5
|
mitogen-activated protein kinase kinase 5
|
|
MAP2K6
|
mitogen-activated protein kinase kinase 6
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK13
|
mitogen-activated protein kinase 13
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPT
|
microtubule-associated protein tau
|
|
MATN3
|
matrilin 3
|
|
MAVS
|
mitochondrial antiviral signaling protein
|
|
MAX
|
MYC associated factor X
|
|
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor)
|
|
MB21D1
|
Mab-21 domain containing 1
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED12
|
mediator complex subunit 12
|
|
MED28
|
mediator complex subunit 28
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MEF2D
|
myocyte enhancer factor 2D
|
|
MEIS1
|
Meis homeobox 1
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MEOX2
|
mesenchyme homeobox 2
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGAT5
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MINA
|
MYC induced nuclear antigen
|
|
MIR1-1
|
microRNA 1-1
|
|
MIR1204
|
microRNA 1204
|
|
MIR122
|
microRNA 122
|
|
MIR1226
|
microRNA 1226
|
|
MIR124-1
|
microRNA 124-1
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR1275
|
microRNA 1275
|
|
MIR128-2
|
microRNA 128-2
|
|
MIR132
|
microRNA 132
|
|
MIR138-1
|
microRNA 138-1
|
|
MIR138-2
|
microRNA 138-2
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MIR146A
|
microRNA 146a
|
|
MIR146B
|
microRNA 146b
|
|
MIR155
|
microRNA 155
|
|
MIR15A
|
microRNA 15a
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR17
|
microRNA 17
|
|
MIR182
|
microRNA 182
|
|
MIR183
|
microRNA 183
|
|
MIR185
|
microRNA 185
|
|
MIR190A
|
microRNA 190a
|
|
MIR19B1
|
microRNA 19b-1
|
|
MIR19B2
|
microRNA 19b-2
|
|
MIR200B
|
microRNA 200b
|
|
MIR200C
|
microRNA 200c
|
|
MIR203A
|
microRNA 203a
|
|
MIR205
|
microRNA 205
|
|
MIR20A
|
microRNA 20a
|
|
MIR21
|
microRNA 21
|
|
MIR210
|
microRNA 210
|
|
MIR214
|
microRNA 214
|
|
MIR22
|
microRNA 22
|
|
MIR221
|
microRNA 221
|
|
MIR24-2
|
microRNA 24-2
|
|
MIR25
|
microRNA 25
|
|
MIR27A
|
microRNA 27a
|
|
MIR29C
|
microRNA 29c
|
|
MIR302A
|
microRNA 302a
|
|
MIR320D1
|
microRNA 320d-1
|
|
MIR34A
|
microRNA 34a
|
|
MIR425
|
microRNA 425
|
|
MIR4723
|
microRNA 4723
|
|
MIR493
|
microRNA 493
|
|
MIR498
|
microRNA 498
|
|
MIR517A
|
microRNA 517a
|
|
MIR663A
|
microRNA 663a
|
|
MIR7-1
|
microRNA 7-1
|
|
MIR762
|
microRNA 762
|
|
MIR9-1
|
microRNA 9-1
|
|
MIR92A1
|
microRNA 92a-1
|
|
MIR93
|
microRNA 93
|
|
MIR96
|
microRNA 96
|
|
MIR99A
|
microRNA 99a
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MLH1
|
mutL homolog 1
|
|
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3
|
|
MLXIP
|
MLX interacting protein
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP10
|
matrix metallopeptidase 10
|
|
MMP11
|
matrix metallopeptidase 11
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP15
|
matrix metallopeptidase 15 (membrane-inserted)
|
|
MMP19
|
matrix metallopeptidase 19
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MN1
|
meningioma (disrupted in balanced translocation) 1
|
|
MNT
|
MAX network transcriptional repressor
|
|
MOK
|
MOK protein kinase
|
|
MPO
|
myeloperoxidase
|
|
MR1
|
major histocompatibility complex, class I-related
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MSN
|
moesin
|
|
MST1
|
macrophage stimulating 1
|
|
MSX1
|
msh homeobox 1
|
|
MSX2
|
msh homeobox 2
|
|
MT1G
|
metallothionein 1G
|
|
MT2A
|
metallothionein 2A
|
|
MTDH
|
metadherin
|
|
MTHFD1
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTSS1
|
metastasis suppressor 1
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming
|
|
MUC8
|
mucin 8
|
|
MVP
|
major vault protein
|
|
MX1
|
MX dynamin-like GTPase 1
|
|
MXD1
|
MAX dimerization protein 1
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYBBP1A
|
MYB binding protein (P160) 1a
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCL
|
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
MYOCD
|
myocardin
|
|
MYOD1
|
myogenic differentiation 1
|
|
MYOG
|
myogenin (myogenic factor 4)
|
|
NAB2
|
NGFI-A binding protein 2 (EGR1 binding protein 2)
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCF1
|
neutrophil cytosolic factor 1
|
|
NCMAP
|
noncompact myelin associated protein
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
|
NCR3
|
natural cytotoxicity triggering receptor 3
|
|
NDN
|
necdin, melanoma antigen (MAGE) family member
|
|
NDP
|
Norrie disease (pseudoglioma)
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NDRG2
|
NDRG family member 2
|
|
NDUFA2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa
|
|
NEK8
|
NIMA-related kinase 8
|
|
NEK9
|
NIMA-related kinase 9
|
|
NELFA
|
negative elongation factor complex member A
|
|
NELFB
|
negative elongation factor complex member B
|
|
NELL1
|
NEL-like 1 (chicken)
|
|
NEU3
|
sialidase 3 (membrane sialidase)
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFAT5
|
nuclear factor of activated T-cells 5, tonicity-responsive
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFATC4
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NFKBIZ
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta
|
|
NFX1
|
nuclear transcription factor, X-box binding 1
|
|
NFYA
|
nuclear transcription factor Y, alpha
|
|
NFYC
|
nuclear transcription factor Y, gamma
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NGFR
|
nerve growth factor receptor
|
|
NKRF
|
NFKB repressing factor
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NLK
|
nemo-like kinase
|
|
NLRC5
|
NLR family, CARD domain containing 5
|
|
NLRP2
|
NLR family, pyrin domain containing 2
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NMI
|
N-myc (and STAT) interactor
|
|
NMT2
|
N-myristoyltransferase 2
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NODAL
|
nodal growth differentiation factor
|
|
NONO
|
non-POU domain containing, octamer-binding
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
NOX1
|
NADPH oxidase 1
|
|
NOX4
|
NADPH oxidase 4
|
|
NOXO1
|
NADPH oxidase organizer 1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPA
|
natriuretic peptide A
|
|
NPPB
|
natriuretic peptide B
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NQO2
|
NAD(P)H dehydrogenase, quinone 2
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
NR1D1
|
nuclear receptor subfamily 1, group D, member 1
|
|
NR1H2
|
nuclear receptor subfamily 1, group H, member 2
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
NR2C2
|
nuclear receptor subfamily 2, group C, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
NRCAM
|
neuronal cell adhesion molecule
|
|
NREP
|
neuronal regeneration related protein
|
|
NRG1
|
neuregulin 1
|
|
NRP1
|
neuropilin 1
|
|
NRP2
|
neuropilin 2
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
NTN1
|
netrin 1
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NTS
|
neurotensin
|
|
NUAK2
|
NUAK family, SNF1-like kinase, 2
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
NUDT1
|
nudix (nucleoside diphosphate linked moiety X)-type motif 1
|
|
NUP98
|
nucleoporin 98kDa
|
|
ODC1
|
ornithine decarboxylase 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OLA1
|
Obg-like ATPase 1
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
OPTN
|
optineurin
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
ORAI3
|
ORAI calcium release-activated calcium modulator 3
|
|
OSCAR
|
osteoclast associated, immunoglobulin-like receptor
|
|
OSGIN1
|
oxidative stress induced growth inhibitor 1
|
|
OSM
|
oncostatin M
|
|
OTUB1
|
OTU deubiquitinase, ubiquitin aldehyde binding 1
|
|
OTUB2
|
OTU deubiquitinase, ubiquitin aldehyde binding 2
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
P2RX1
|
purinergic receptor P2X, ligand gated ion channel, 1
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARG
|
poly (ADP-ribose) glycohydrolase
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PAX5
|
paired box 5
|
|
PBRM1
|
polybromo 1
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PCIF1
|
PDX1 C-terminal inhibiting factor 1
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDCD1
|
programmed cell death 1
|
|
PDE1A
|
phosphodiesterase 1A, calmodulin-dependent
|
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDIA3
|
protein disulfide isomerase family A, member 3
|
|
PDK1
|
pyruvate dehydrogenase kinase, isozyme 1
|
|
PDLIM2
|
PDZ and LIM domain 2 (mystique)
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PDPN
|
podoplanin
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PDYN
|
prodynorphin
|
|
PDZD2
|
PDZ domain containing 2
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PEG10
|
paternally expressed 10
|
|
PELI1
|
pellino E3 ubiquitin protein ligase 1
|
|
PENK
|
proenkephalin
|
|
PER2
|
period circadian clock 2
|
|
PERP
|
PERP, TP53 apoptosis effector
|
|
PF4
|
platelet factor 4
|
|
PFDN2
|
prefoldin subunit 2
|
|
PFDN5
|
prefoldin subunit 5
|
|
PFKFB2
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PHB
|
prohibitin
|
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked
|
|
PHLDA1
|
pleckstrin homology-like domain, family A, member 1
|
|
PHLDA2
|
pleckstrin homology-like domain, family A, member 2
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
|
PI4KA
|
phosphatidylinositol 4-kinase, catalytic, alpha
|
|
PIAS1
|
protein inhibitor of activated STAT, 1
|
|
PIAS4
|
protein inhibitor of activated STAT, 4
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIM2
|
Pim-2 proto-oncogene, serine/threonine kinase
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PINX1
|
PIN2/TERF1 interacting, telomerase inhibitor 1
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PKIB
|
protein kinase (cAMP-dependent, catalytic) inhibitor beta
|
|
PKMYT1
|
protein kinase, membrane associated tyrosine/threonine 1
|
|
PLA2G16
|
phospholipase A2, group XVI
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLA2G4C
|
phospholipase A2, group IVC (cytosolic, calcium-independent)
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLA2R1
|
phospholipase A2 receptor 1, 180kDa
|
|
PLAGL1
|
pleiomorphic adenoma gene-like 1
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLEKHF2
|
pleckstrin homology domain containing, family F (with FYVE domain) member 2
|
|
PLEKHG4
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 4
|
|
PLG
|
plasminogen
|
|
PLIN1
|
perilipin 1
|
|
PLIN2
|
perilipin 2
|
|
PLK1
|
polo-like kinase 1
|
|
PLSCR1
|
phospholipid scramblase 1
|
|
PLTP
|
phospholipid transfer protein
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
PML
|
promyelocytic leukemia
|
|
PNPT1
|
polyribonucleotide nucleotidyltransferase 1
|
|
POLDIP3
|
polymerase (DNA-directed), delta interacting protein 3
|
|
POLH
|
polymerase (DNA directed), eta
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
POLR3H
|
polymerase (RNA) III (DNA directed) polypeptide H (22.9kD)
|
|
POMC
|
proopiomelanocortin
|
|
PON1
|
paraoxonase 1
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPARGC1B
|
peroxisome proliferator-activated receptor gamma, coactivator 1 beta
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like
|
|
PPP2R2B
|
protein phosphatase 2, regulatory subunit B, beta
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PRAP1
|
proline-rich acidic protein 1
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRDM14
|
PR domain containing 14
|
|
PRDM2
|
PR domain containing 2, with ZNF domain
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRDX2
|
peroxiredoxin 2
|
|
PRDX3
|
peroxiredoxin 3
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKAG1
|
protein kinase, AMP-activated, gamma 1 non-catalytic subunit
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCH
|
protein kinase C, eta
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRKCSH
|
protein kinase C substrate 80K-H
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD1
|
protein kinase D1
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PRMT1
|
protein arginine methyltransferase 1
|
|
PRMT5
|
protein arginine methyltransferase 5
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PRODH
|
proline dehydrogenase (oxidase) 1
|
|
PROK1
|
prokineticin 1
|
|
PROK2
|
prokineticin 2
|
|
PSEN2
|
presenilin 2
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
|
PSME1
|
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha)
|
|
PTCHD4
|
patched domain containing 4
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDR2
|
prostaglandin D2 receptor 2
|
|
PTGER1
|
prostaglandin E receptor 1 (subtype EP1), 42kDa
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGER3
|
prostaglandin E receptor 3 (subtype EP3)
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGER4P3
|
prostaglandin E receptor 4 (subtype EP4) pseudogene 3
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGES2
|
prostaglandin E synthase 2
|
|
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP)
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTK7
|
protein tyrosine kinase 7 (inactive)
|
|
PTN
|
pleiotrophin
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN13
|
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1
|
|
PTS
|
6-pyruvoyltetrahydropterin synthase
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PTX3
|
pentraxin 3, long
|
|
PVR
|
poliovirus receptor
|
|
PVT1
|
Pvt1 oncogene (non-protein coding)
|
|
PYCARD
|
PYD and CARD domain containing
|
|
RAB25
|
RAB25, member RAS oncogene family
|
|
RAB6A
|
RAB6A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD21
|
RAD21 homolog (S. pombe)
|
|
RAE1
|
ribonucleic acid export 1
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAG1
|
recombination activating gene 1
|
|
RAG2
|
recombination activating gene 2
|
|
RAN
|
RAN, member RAS oncogene family
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAP1GDS1
|
RAP1, GTP-GDP dissociation stimulator 1
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARRES1
|
retinoic acid receptor responder (tazarotene induced) 1
|
|
RARRES3
|
retinoic acid receptor responder (tazarotene induced) 3
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RASEF
|
RAS and EF-hand domain containing
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5
|
|
RB1
|
retinoblastoma 1
|
|
RB1CC1
|
RB1-inducible coiled-coil 1
|
|
RBBP8
|
retinoblastoma binding protein 8
|
|
RBL1
|
retinoblastoma-like 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region
|
|
RBX1
|
ring-box 1, E3 ubiquitin protein ligase
|
|
RCAN1
|
regulator of calcineurin 1
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
REN
|
renin
|
|
REPS2
|
RALBP1 associated Eps domain containing 2
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
REV3L
|
REV3-like, polymerase (DNA directed), zeta, catalytic subunit
|
|
RFX1
|
regulatory factor X, 1 (influences HLA class II expression)
|
|
RGCC
|
regulator of cell cycle
|
|
RGS5
|
regulator of G-protein signaling 5
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RHOA
|
ras homolog family member A
|
|
RHOB
|
ras homolog family member B
|
|
RHOBTB2
|
Rho-related BTB domain containing 2
|
|
RHOC
|
ras homolog family member C
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RIPK2
|
receptor-interacting serine-threonine kinase 2
|
|
RIPK3
|
receptor-interacting serine-threonine kinase 3
|
|
RNASE7
|
ribonuclease, RNase A family, 7
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RND3
|
Rho family GTPase 3
|
|
RNF2
|
ring finger protein 2
|
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila)
|
|
ROBO4
|
roundabout, axon guidance receptor, homolog 4 (Drosophila)
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
RORA
|
RAR-related orphan receptor A
|
|
RPA2
|
replication protein A2, 32kDa
|
|
RPL11
|
ribosomal protein L11
|
|
RPL26
|
ribosomal protein L26
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RPS6KA4
|
ribosomal protein S6 kinase, 90kDa, polypeptide 4
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RPS6KA6
|
ribosomal protein S6 kinase, 90kDa, polypeptide 6
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RRM2B
|
ribonucleotide reductase M2 B (TP53 inducible)
|
|
RUMY1
|
regulator of UNG2 and MKLN1 interacting yippee protein 1
|
|
RUMY2
|
RUMY family member 2
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RYBP
|
RING1 and YY1 binding protein
|
|
RYK
|
receptor-like tyrosine kinase
|
|
S100A1
|
S100 calcium binding protein A1
|
|
S100A2
|
S100 calcium binding protein A2
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A7
|
S100 calcium binding protein A7
|
|
S100B
|
S100 calcium binding protein B
|
|
S1PR3
|
sphingosine-1-phosphate receptor 3
|
|
SAA1
|
serum amyloid A1
|
|
SAA@
|
serum amyloid A1 cluster
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SAMD4A
|
sterile alpha motif domain containing 4A
|
|
SAT1
|
spermidine/spermine N1-acetyltransferase 1
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SCNN1B
|
sodium channel, non voltage gated 1 beta subunit
|
|
SCNN1G
|
sodium channel, non voltage gated 1 gamma subunit
|
|
SDC1
|
syndecan 1
|
|
SDC2
|
syndecan 2
|
|
SDC3
|
syndecan 3
|
|
SELE
|
selectin E
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SELPLG
|
selectin P ligand
|
|
SEMA7A
|
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group)
|
|
SENP1
|
SUMO1/sentrin specific peptidase 1
|
|
SEPT4
|
septin 4
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA12
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SERPINB3
|
serpin peptidase inhibitor, clade B (ovalbumin), member 3
|
|
SERPINB4
|
serpin peptidase inhibitor, clade B (ovalbumin), member 4
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINB9
|
serpin peptidase inhibitor, clade B (ovalbumin), member 9
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SERPINF2
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2
|
|
SESN2
|
sestrin 2
|
|
SET
|
SET nuclear proto-oncogene
|
|
SF1
|
splicing factor 1
|
|
SF3B2
|
splicing factor 3b, subunit 2, 145kDa
|
|
SF3B4
|
splicing factor 3b, subunit 4, 49kDa
|
|
SFN
|
stratifin
|
|
SFPQ
|
splicing factor proline/glutamine-rich
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFTPA1
|
surfactant protein A1
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SH2D1A
|
SH2 domain containing 1A
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHH
|
sonic hedgehog
|
|
SIGLEC1
|
sialic acid binding Ig-like lectin 1, sialoadhesin
|
|
SIGLEC8
|
sialic acid binding Ig-like lectin 8
|
|
SIN3A
|
SIN3 transcription regulator family member A
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SIRT1
|
sirtuin 1
|
|
SIRT6
|
sirtuin 6
|
|
SIVA1
|
SIVA1, apoptosis-inducing factor
|
|
SKI
|
SKI proto-oncogene
|
|
SKIL
|
SKI-like proto-oncogene
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLAMF1
|
signaling lymphocytic activation molecule family member 1
|
|
SLC15A1
|
solute carrier family 15 (oligopeptide transporter), member 1
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
|
SLC20A1
|
solute carrier family 20 (phosphate transporter), member 1
|
|
SLC25A4
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4
|
|
SLC25A6
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6
|
|
SLC26A3
|
solute carrier family 26 (anion exchanger), member 3
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC2A5
|
solute carrier family 2 (facilitated glucose/fructose transporter), member 5
|
|
SLC31A1
|
solute carrier family 31 (copper transporter), member 1
|
|
SLC33A1
|
solute carrier family 33 (acetyl-CoA transporter), member 1
|
|
SLC38A2
|
solute carrier family 38, member 2
|
|
SLC39A6
|
solute carrier family 39 (zinc transporter), member 6
|
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1
|
|
SLC44A1
|
solute carrier family 44 (choline transporter), member 1
|
|
SLC44A2
|
solute carrier family 44 (choline transporter), member 2
|
|
SLC5A1
|
solute carrier family 5 (sodium/glucose cotransporter), member 1
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC7A1
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1
|
|
SLC7A11
|
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11
|
|
SLC7A2
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2
|
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLC9A2
|
solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLX4
|
SLX4 structure-specific endonuclease subunit
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD6
|
SMAD family member 6
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCA1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SMOX
|
spermine oxidase
|
|
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal
|
|
SMPD2
|
sphingomyelin phosphodiesterase 2, neutral membrane (neutral sphingomyelinase)
|
|
SMPD3
|
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II)
|
|
SMPDL3A
|
sphingomyelin phosphodiesterase, acid-like 3A
|
|
SMURF2
|
SMAD specific E3 ubiquitin protein ligase 2
|
|
SMYD3
|
SET and MYND domain containing 3
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNX5
|
sorting nexin 5
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SOST
|
sclerostin
|
|
SOX1
|
SRY (sex determining region Y)-box 1
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX3
|
SRY (sex determining region Y)-box 3
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SP1
|
Sp1 transcription factor
|
|
SP3
|
Sp3 transcription factor
|
|
SP7
|
Sp7 transcription factor
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPHK2
|
sphingosine kinase 2
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPIB
|
Spi-B transcription factor (Spi-1/PU.1 related)
|
|
SPN
|
sialophorin
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SQSTM1
|
sequestosome 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SREBF2
|
sterol regulatory element binding transcription factor 2
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
SSB
|
Sjogren syndrome antigen B (autoantigen La)
|
|
SST
|
somatostatin
|
|
ST3GAL1
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 1
|
|
STARD4
|
StAR-related lipid transfer (START) domain containing 4
|
|
STARD9
|
StAR-related lipid transfer (START) domain containing 9
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STC1
|
stanniocalcin 1
|
|
STC2
|
stanniocalcin 2
|
|
STIL
|
SCL/TAL1 interrupting locus
|
|
STIM1
|
stromal interaction molecule 1
|
|
STK11
|
serine/threonine kinase 11
|
|
STK26
|
serine/threonine protein kinase 26
|
|
STK3
|
serine/threonine kinase 3
|
|
STK4
|
serine/threonine kinase 4
|
|
STPG1
|
sperm-tail PG-rich repeat containing 1
|
|
STRADA
|
STE20-related kinase adaptor alpha
|
|
SULT1A3
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3
|
|
SULT2A1
|
sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SUMO3
|
small ubiquitin-like modifier 3
|
|
SUPT4H1
|
suppressor of Ty 4 homolog 1 (S. cerevisiae)
|
|
SUPT5H
|
suppressor of Ty 5 homolog (S. cerevisiae)
|
|
SUPV3L1
|
suppressor of var1, 3-like 1 (S. cerevisiae)
|
|
SUV39H1
|
suppressor of variegation 3-9 homolog 1 (Drosophila)
|
|
SUV39H2
|
suppressor of variegation 3-9 homolog 2 (Drosophila)
|
|
SYK
|
spleen tyrosine kinase
|
|
SYNGAP1
|
synaptic Ras GTPase activating protein 1
|
|
SYTL1
|
synaptotagmin-like 1
|
|
TAC1
|
tachykinin, precursor 1
|
|
TADA3
|
transcriptional adaptor 3
|
|
TAOK2
|
TAO kinase 2
|
|
TARBP1
|
TAR (HIV-1) RNA binding protein 1
|
|
TBK1
|
TANK-binding kinase 1
|
|
TBX2
|
T-box 2
|
|
TBX21
|
T-box 21
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TCEB3
|
transcription elongation factor B (SIII), polypeptide 3 (110kDa, elongin A)
|
|
TCF23
|
transcription factor 23
|
|
TCF3
|
transcription factor 3
|
|
TCF7
|
transcription factor 7 (T-cell specific, HMG-box)
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TDGF1
|
teratocarcinoma-derived growth factor 1
|
|
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor)
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFB1M
|
transcription factor B1, mitochondrial
|
|
TFB2M
|
transcription factor B2, mitochondrial
|
|
TFF1
|
trefoil factor 1
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM2
|
transglutaminase 2
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THEM4
|
thioesterase superfamily member 4
|
|
THOC1
|
THO complex 1
|
|
THOP1
|
thimet oligopeptidase 1
|
|
THRA
|
thyroid hormone receptor, alpha
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TIAF1
|
TGFB1-induced anti-apoptotic factor 1
|
|
TICAM1
|
toll-like receptor adaptor molecule 1
|
|
TICAM2
|
toll-like receptor adaptor molecule 2
|
|
TIMD4
|
T-cell immunoglobulin and mucin domain containing 4
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TIMP4
|
TIMP metallopeptidase inhibitor 4
|
|
TIRAP
|
toll-interleukin 1 receptor (TIR) domain containing adaptor protein
|
|
TJP1
|
tight junction protein 1
|
|
TK1
|
thymidine kinase 1, soluble
|
|
TLE3
|
transducin-like enhancer of split 3
|
|
TLR1
|
toll-like receptor 1
|
|
TLR10
|
toll-like receptor 10
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR6
|
toll-like receptor 6
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TLR9
|
toll-like receptor 9
|
|
TLX3
|
T-cell leukemia homeobox 3
|
|
TM4SF5
|
transmembrane 4 L six family member 5
|
|
TMBIM6
|
transmembrane BAX inhibitor motif containing 6
|
|
TMEM134
|
transmembrane protein 134
|
|
TMEM173
|
transmembrane protein 173
|
|
TMPRSS4
|
transmembrane protease, serine 4
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
|
TNFRSF18
|
tumor necrosis factor receptor superfamily, member 18
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF25
|
tumor necrosis factor receptor superfamily, member 25
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF15
|
tumor necrosis factor (ligand) superfamily, member 15
|
|
TNFSF18
|
tumor necrosis factor (ligand) superfamily, member 18
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNR
|
tenascin R
|
|
TNS4
|
tensin 4
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOPBP1
|
topoisomerase (DNA) II binding protein 1
|
|
TOR1B
|
torsin family 1, member B (torsin B)
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TP53INP1
|
tumor protein p53 inducible nuclear protein 1
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TRA2B
|
transformer 2 beta homolog (Drosophila)
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TRAF3IP2
|
TRAF3 interacting protein 2
|
|
TRAF4
|
TNF receptor-associated factor 4
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRAP1
|
TNF receptor-associated protein 1
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
|
TREM2
|
triggering receptor expressed on myeloid cells 2
|
|
TREX1
|
three prime repair exonuclease 1
|
|
TRIB3
|
tribbles pseudokinase 3
|
|
TRIM13
|
tripartite motif containing 13
|
|
TRIM21
|
tripartite motif containing 21
|
|
TRIM24
|
tripartite motif containing 24
|
|
TRIM28
|
tripartite motif containing 28
|
|
TRIM32
|
tripartite motif containing 32
|
|
TRIM4
|
tripartite motif containing 4
|
|
TRIP4
|
thyroid hormone receptor interactor 4
|
|
TRIP6
|
thyroid hormone receptor interactor 6
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPC1
|
transient receptor potential cation channel, subfamily C, member 1
|
|
TRPC4
|
transient receptor potential cation channel, subfamily C, member 4
|
|
TRPC5
|
transient receptor potential cation channel, subfamily C, member 5
|
|
TRPM2
|
transient receptor potential cation channel, subfamily M, member 2
|
|
TRPM7
|
transient receptor potential cation channel, subfamily M, member 7
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSC22D3
|
TSC22 domain family, member 3
|
|
TSPO
|
translocator protein (18kDa)
|
|
TUT1
|
terminal uridylyl transferase 1, U6 snRNA-specific
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TWIST2
|
twist family bHLH transcription factor 2
|
|
TXN
|
thioredoxin
|
|
TXNIP
|
thioredoxin interacting protein
|
|
TXNRD1
|
thioredoxin reductase 1
|
|
TYMP
|
thymidine phosphorylase
|
|
TYMS
|
thymidylate synthetase
|
|
TYR
|
tyrosinase
|
|
TYROBP
|
TYRO protein tyrosine kinase binding protein
|
|
U2AF2
|
U2 small nuclear RNA auxiliary factor 2
|
|
UBD
|
ubiquitin D
|
|
UBQLN1
|
ubiquilin 1
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A6
|
UDP glucuronosyltransferase 1 family, polypeptide A6
|
|
ULBP1
|
UL16 binding protein 1
|
|
ULBP2
|
UL16 binding protein 2
|
|
ULK1
|
unc-51 like autophagy activating kinase 1
|
|
UNC5A
|
unc-5 homolog A (C. elegans)
|
|
UNC5C
|
unc-5 homolog C (C. elegans)
|
|
USF1
|
upstream transcription factor 1
|
|
USF2
|
upstream transcription factor 2, c-fos interacting
|
|
VASH1
|
vasohibin 1
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCAN
|
versican
|
|
VDAC1
|
voltage-dependent anion channel 1
|
|
VDAC2
|
voltage-dependent anion channel 2
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIL1
|
villin 1
|
|
VIM
|
vimentin
|
|
VMP1
|
vacuole membrane protein 1
|
|
VPRBP
|
Vpr (HIV-1) binding protein
|
|
VSIG4
|
V-set and immunoglobulin domain containing 4
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
|
VTN
|
vitronectin
|
|
VWA1
|
von Willebrand factor A domain containing 1
|
|
VWF
|
von Willebrand factor
|
|
WAPAL
|
wings apart-like homolog (Drosophila)
|
|
WASF2
|
WAS protein family, member 2
|
|
WDR36
|
WD repeat domain 36
|
|
WDR5
|
WD repeat domain 5
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
WHSC1
|
Wolf-Hirschhorn syndrome candidate 1
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WISP1
|
WNT1 inducible signaling pathway protein 1
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT10B
|
wingless-type MMTV integration site family, member 10B
|
|
WNT3
|
wingless-type MMTV integration site family, member 3
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
|
WNT9A
|
wingless-type MMTV integration site family, member 9A
|
|
WRAP53
|
WD repeat containing, antisense to TP53
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XAF1
|
XIAP associated factor 1
|
|
XBP1
|
X-box binding protein 1
|
|
XDH
|
xanthine dehydrogenase
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XPO1
|
exportin 1
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|
|
XYLT1
|
xylosyltransferase I
|
|
YAP1
|
Yes-associated protein 1
|
|
YBX1
|
Y box binding protein 1
|
|
YES1
|
YES proto-oncogene 1, Src family tyrosine kinase
|
|
YPEL3
|
yippee-like 3 (Drosophila)
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
YY1
|
YY1 transcription factor
|
|
ZBTB10
|
zinc finger and BTB domain containing 10
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
|
ZBTB17
|
zinc finger and BTB domain containing 17
|
|
ZC3H12A
|
zinc finger CCCH-type containing 12A
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZFP36
|
ZFP36 ring finger protein
|
|
ZKSCAN3
|
zinc finger with KRAB and SCAN domains 3
|
|
ZMYND11
|
zinc finger, MYND-type containing 11
|
|
ZNF148
|
zinc finger protein 148
|
